Description

FOXO4-DRI 10mg (Proxofim) – Targeting Senescent Cells for Healthier Aging

FOXO4-DRI (D-Retro-Inverso) is a specially engineered version of the natural FOXO4 protein, designed to help eliminate harmful, aged cells known as senescent cells. These dysfunctional cells accumulate over time and contribute to the aging process, tissue damage, and various age-related diseases.

Backed by promising research, FOXO4-DRI offers a novel way to improve tissue health, support organ function, and potentially slow biological aging by removing these non-functioning cells from the body.

What Is FOXO4-DRI?

FOXO4-DRI is a synthetic peptide modeled after the FOXO4 protein but with a twist: its amino acid structure has been reversed and modified with D-amino acids—mirror versions of the natural L-amino acids found in the body. This clever design makes the peptide much more resistant to breakdown, allowing it to stay active in the body longer.

Its primary function? Disrupting the interaction between FOXO4 and the p53 protein. Under normal conditions, FOXO4 keeps senescent cells alive by blocking p53. FOXO4-DRI steps in, blocks FOXO4, and frees up p53 to trigger apoptosis—or programmed cell death—in these aged cells. The result is a sort of “cellular spring cleaning” that helps promote tissue regeneration and overall biological rejuvenation.

How D-Retro-Inverso Peptides Work

Retro-inverso peptides like FOXO4-DRI are built with a reversed amino acid sequence using D-amino acids instead of the typical L-forms. This design offers several advantages:

• Increased stability

• Improved bioavailability

• Lower immune response risk

• Longer lasting activity in the body

These properties make retro-inverso peptides attractive for pharmaceutical research, especially in fields like aging, cancer, and chronic inflammation.

How FOXO4-DRI Supports Anti-Aging

Research in mice has shown that FOXO4-DRI selectively targets senescent cells and helps restore balance to tissues affected by aging. Here’s how it works:

• Triggers Apoptosis in Senescent Cells: By unblocking the p53 protein, FOXO4-DRI allows aged, damaged cells to be cleared out.

• Improves Tissue Function: With fewer “zombie” cells, tissues operate more efficiently and may even regenerate more effectively.

• Reduces Biological Age: Removing dysfunctional cells can help make tissues behave and function more like those of a younger person or animal.

Potential Applications in Research

FOXO4-DRI is being explored for its potential in age-related and degenerative conditions:

1. Insulin Signaling and Metabolic Health

FOXO4 proteins influence how the body responds to insulin and related growth factors. Research suggests FOXO4-DRI might help regulate blood sugar levels and reduce complications tied to metabolic disorders like diabetes.

2. Cardiovascular Health

Aging reduces the heart’s natural ability to break down and remove damaged proteins. FOXO4-DRI may enhance this internal cleanup system, potentially improving heart health and preventing age-related decline.

3. Neurodegenerative Conditions

Disrupted protein clearance is a common factor in diseases like Alzheimer’s and Parkinson’s. By improving cellular recycling pathways, FOXO4-DRI could offer insights or even support research into slowing cognitive decline.

Scientific Background

The development of FOXO4-DRI was inspired by research led by Dr. Peter de Keizer and others studying how aged cells contribute to disease and aging. By specifically removing these cells, researchers believe it’s possible to “reset” tissues and improve healthspan.

Molecular Formula: C₂₂₈H₃₈₈N₆₄O₆₄ Molecular Weight: 5358.05 g/mol Synonyms: Forkhead box protein 04, Proxofim, AFX, AFX1, MLLT7

Important Note

FOXO4-DRI is intended strictly for laboratory and in-vitro research purposes only. It is not approved for human or animal use, and any form of bodily introduction is strictly prohibited.